Pricing Log in Create free account

Precision BioSciences, Inc. (DTIL) vs Ocugen, Inc. (OCGN)

Precision BioSciences, Inc. and Ocugen, Inc. are both Biotechnology companies. Precision BioSciences, Inc. and Ocugen, Inc. are of similar size ($276.9M and $275.7M). Ocugen, Inc. grew revenue faster over the last twelve months: −11.0% against −11.9%. Precision BioSciences, Inc. has the higher net margin (0.00% vs −1,367.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Precision BioSciences, Inc. leads on 9 and Ocugen, Inc. on 5.

Valuation

Metric DTIL OCGN Biotechnology median
P/E n/m n/m 10.60
P/S 6.54 66.01 9.40
P/B 5.70 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 5.22 48.75 9.02
Earnings yield (11.41%) (21.57%) (32.88%)
Free cash flow yield (17.77%) (20.26%) (23.13%)

Profitability

Metric DTIL OCGN Biotechnology median
Gross margin 100.00% 100.00% 68.51%
Operating margin 0.00% (1,444.47%) 0.00%
Net margin 0.00% (1,367.61%) 0.00%
Free cash flow margin 0.00% (1,337.16%) 0.00%
Return on equity (112.69%) 923.92% (51.96%)
Return on assets (36.04%) (78.91%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric DTIL OCGN Biotechnology median
Revenue growth (TTM) (11.87%) (11.01%) 6.76%
EPS growth (last fiscal year) (442.31%) (15.00%) 29.88%
Revenue growth, 5-year CAGR 7.13% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DTIL OCGN Biotechnology median
Debt to equity 0.43 (0.10) 0.00
Current ratio 10.47 0.77 4.97
Net debt to EBITDA 1.86 (0.17) 1.01

Dividend

Metric DTIL OCGN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric DTIL OCGN Biotechnology median
Market cap 275.73m 276.88m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack